“LIQVOR” reorganized its production platforms and processes in 1995 in accordance with WHO cGMP instructions in order to present itself as a high-quality pharmaceutical manufacturer in local and international markets to have a quality and efficient product.
Research and development
From the very first day of its establishment, the central principle of “LIQVOR” is quality, which is one of the main recipe of the Company’s development and entry into new international markets.
The international cooperation and export activity of “LIQVOR” started in 1999.
Today the Company has a wide geography of exports, more than 70% of its products are presented in the countries of Eurasia, Central Asia and the Middle East.
“LIQVOR” cooperates with the leading and large distributors, clinics and medical community of the above-mentioned countries, and this long-term cooperation proves high therapeutic efficiency and the quality of the Company’s products.
“LIQVOR” is the leader in the volume of medicines exported from Armenia with a share of more than 40%.
During the period from 09/08/2020 to 11/08/2020 within the framework
Liqvor was the General Sponsor of the International Pharmaceutical Conference «Drug Development: from design to customer (DDDC 2019)»
The International Pharmaceutical Conference “Drug Development: from design to customer